• Utilize strong business and analytical acumen coupled with a high level of strategic partnership expertise to to drive global sales, lead marketing, and develop strategic accounts strategy. • Designed B2B and Professional Solution business models that were key to the increase of overall sales by 72%, Professional Solutions sales by 250%, and B2B sales by 60% in CY22.• Spearheaded the B2B footprint expansion to seven additional countries and built a B2B Marketing roadmap for each.• Overhauled an underperforming Professional Solutions process, implementing a streamlined strategies that advanced an increase in sales.

• Headed sales and margin commitments for the US Peripheral Vascular (PV) Sales Organization. • Aligned focus across an Interventional Radiology sales organization of 30 Sales Representatives. • Steered a PV Sales Team comprised of 150 Sales Representatives and 100 Clinical Specialists to secure the #1 placement in the overall market.• Outperformed the PV Annual Operating Plan for three years with 106%; refocused team after COVID intermission with a forecast to meet plan in 2022.• Successfully executed the InPact AV launch plan, securing 58 market share points in two years.• Launched a sales initiative during the Paclitaxel issue that led to an incremental six share points.• Awarded the 2019 Vendor of the Year for Vizient and Captis.• Executive leadership sponsor for multiple employee resource groups including the African Descent Network and the Medtronic Women's Network.

• Integrated the Covidien Peripheral Vascular Business Unit into Medtronic's Cardiovascular Group. • Steered APV strategic leverage programs to include Drug Coated Balloon (DCB). • Expanded the executive leadership role post-acquisition to devise contracting plans that increased revenue and profit margins for an $1.8B cardiovascular business.• Led the Drug Coated Balloon to reach $1M in sales in first quarter of launch.• Drove the seamless integration of capitation pricing programs into Medtronic's SAP system.• Awarded the 2014 Innovation Award for the delivery of $250M of incremental revenue without adding any resources.

• Headed the creation and advancement of the national accounts team to include pricing and contracting. • Established ev3 peripheral vascular (PV) and neurovascular (NV) strategic contracting plans. • Promoted post-acquisition to an expanded leadership role encompassing all strategic planning for Covidien business units; served on the executive leadership board for the Covidien/Medtronic business acquisition.• Expanded ev3's market capital from $600M to $2.6B, boosting company revenue to $1B by increasing the total number of accounts by 27%, with an average monthly sales per account by 21%.• Grew target accounts by 7% in FY14, generating double digit growth for five of six years.• Received the 2011 Process Improvement Award for delivering $10M in incremental revenue with no additional resources Additional ExperienceVice President of Corporate Sales, Coloplast Corporation, Minneapolis, MNCorporate Accounts Director, St. Jude Medical United States Division, Minneapolis, MNDirector of Cardiac Rhythm Management Market Development, St. Jude Medical United States Division, Minneapolis, MNDirector of Cardiac Surgery Global Product Marketing, St. Jude Medical United States Division, St. Paul, MNVice President of Global Sales & Marketing, NeuroVax, Minneapolis, MNNorth Central Regional Sales Director, Key Acute Coronary Syndrome, Schering-Plough, Minneapolis, MN